Resurgence of influenza and enterovirus infections in Taiwan post-COVID-19: A nationwide surveillance study

IF 4.7 3区医学 Q1 INFECTIOUS DISEASES

Journal of Infection and Public Health Pub Date : 2024-10-05 DOI:10.1016/j.jiph.2024.102560

Nan-Chang Chiu , Daniel Tsung-Ning Huang , Shun-Long Weng , Hsin Chi , Yu-Lin Tai , Ya-Ning Huang , Hsiang Huang , Wei-Te Lei , Lung Chang , Chien-Yu Lin

{"title":"Resurgence of influenza and enterovirus infections in Taiwan post-COVID-19: A nationwide surveillance study","authors":"Nan-Chang Chiu , Daniel Tsung-Ning Huang , Shun-Long Weng , Hsin Chi , Yu-Lin Tai , Ya-Ning Huang , Hsiang Huang , Wei-Te Lei , Lung Chang , Chien-Yu Lin","doi":"10.1016/j.jiph.2024.102560","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The global impact of COVID-19 has prompted profound shifts in public health policies. The epidemiology of respiratory infectious disease may change in the post-covid era. This study investigates the repercussions of these policies on respiratory infectious diseases, specifically the resurgence of severe influenza and enterovirus infections in the post-COVID-19 era.</div></div><div><h3>Methods</h3><div>Examining the period from January 2020 to December 2023, our nationwide study analyzes data from the Taiwan Centers for Disease Control and Our World in Data. Two distinct phases, containing (Week 1, 2020, to Week 43, 2022) and coexisting (Week 44, 2022, to Week 50, 2023), are scrutinized, emphasizing policy changes and their potential impact on epidemiology.</div></div><div><h3>Results</h3><div>Epidemiological trends reveal a decline in COVID-19 and all-cause pneumonia during the co-existing period but a notable rise in severe influenza and enterovirus infections. Interrupted time series analysis confirms the surge in severe influenza and enterovirus cases post-restriction ease.</div></div><div><h3>Conclusion</h3><div>The post-COVID-19 era introduces challenges with the resurgence of traditional respiratory diseases, necessitating continuous surveillance, timely non-pharmaceutical interventions, and vaccination as crucial strategies. Vigilance and targeted measures by policymakers and healthcare providers are imperative to navigate the evolving landscape of respiratory infectious diseases in the aftermath of the pandemic.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 11","pages":"Article 102560"},"PeriodicalIF":4.7000,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034124002946","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Background

The global impact of COVID-19 has prompted profound shifts in public health policies. The epidemiology of respiratory infectious disease may change in the post-covid era. This study investigates the repercussions of these policies on respiratory infectious diseases, specifically the resurgence of severe influenza and enterovirus infections in the post-COVID-19 era.

Methods

Examining the period from January 2020 to December 2023, our nationwide study analyzes data from the Taiwan Centers for Disease Control and Our World in Data. Two distinct phases, containing (Week 1, 2020, to Week 43, 2022) and coexisting (Week 44, 2022, to Week 50, 2023), are scrutinized, emphasizing policy changes and their potential impact on epidemiology.

Results

Epidemiological trends reveal a decline in COVID-19 and all-cause pneumonia during the co-existing period but a notable rise in severe influenza and enterovirus infections. Interrupted time series analysis confirms the surge in severe influenza and enterovirus cases post-restriction ease.

Conclusion

The post-COVID-19 era introduces challenges with the resurgence of traditional respiratory diseases, necessitating continuous surveillance, timely non-pharmaceutical interventions, and vaccination as crucial strategies. Vigilance and targeted measures by policymakers and healthcare providers are imperative to navigate the evolving landscape of respiratory infectious diseases in the aftermath of the pandemic.

查看原文本刊更多论文

COVID-19后台湾流感和肠病毒感染的复发：全国性监测研究

背景 COVID-19 对全球的影响促使公共卫生政策发生深刻转变。在后 COVID 时代，呼吸道传染病的流行病学可能会发生变化。本研究调查了这些政策对呼吸道传染病的影响，特别是后 COVID-19 时代重症流感和肠道病毒感染的复发情况。方法我们的全国性研究分析了台湾疾病控制中心和 "我们的数据世界 "提供的数据，研究时间为 2020 年 1 月至 2023 年 12 月。结果流行病学趋势显示，在并存时期，COVID-19 和全因肺炎有所下降，但重症流感和肠道病毒感染显著上升。间断时间序列分析证实，限制后重症流感和肠道病毒病例激增。结论后 COVID-19 时代面临着传统呼吸道疾病卷土重来的挑战，因此有必要将持续监测、及时的非药物干预和疫苗接种作为关键策略。决策者和医疗保健提供者必须保持警惕并采取有针对性的措施，以应对大流行后呼吸道传染病不断变化的形势。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Infection and Public Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES

CiteScore

13.10

自引率

1.50%

发文量

203

审稿时长

96 days

期刊介绍： The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other. The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners. It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.